EVAX logo

Evaxion Biotech A/S (EVAX)

Profile

Full Name

Evaxion Biotech A/S

Ticker Symbol

EVAX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Denmark

IPO

February 5, 2021

Indexes

Not included

Website

http://evaxion.ai

Employees

46

Key Details

Price

$1.31(-2.96%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$3.34M(+4480.82% YoY)

Annual EPS

-$10.00(+75.31% YoY)

PE ratio

-

Next earnings date

May 28, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.31
EVAX price is $1.31

30-Day Relative Volume

0.48
EVAX 30-day relative volume is 0.48

Price Performance

Price Most recent change

-2.96%
EVAX price was down -2.96% on Apr 16, 2025

Price YTD change

-68.99%
EVAX price is down -68.99% since January 1st

Price 1-year change

-93.51%
EVAX price is down -93.51% year-on-year

Price 3-year change

-99.09%
EVAX price is down -99.09% over the past 3 years

Price Range

Price All-time high

$634.00
EVAX price is currently -99.79% below its historical high of $634.00

Price 3-year low

$0.84
EVAX price is currently +55.95% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$8.27M
EVAX market capitalization is $8.27 million

Market cap 3-year change

-87.62%
EVAX market capitalization is down -87.62% over the past 3 years

Market cap All-time high

$243.46M
EVAX market capitalization is currently -96.60% below its historical high of $243.46 million

Market cap sector rank

17.93%
EVAX market capitalization is higher than 17.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+505.62%
EVAX shares outstanding is up +505.62% year-on-year

Shares Outstanding 3-Year Change

+1261.04%
EVAX shares outstanding is up +1261.04% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.39
EVAX beta is 0.39

200-day SMA

$8.88
EVAX price is currently -85.25% below its 200-day simple moving average

50-day SMA

$1.98
EVAX price is currently -33.76% below its 50-day simple moving average

RSI

29.22
EVAX 14-day relative strength index is 29.22

Volume

0.48
EVAX 30-day relative volume is 0.48

ATR

$0.13
EVAX average true range is $0.13

10-day Historical Volatility

69.20%
EVAX 10-day historical volatility is 69.20%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$3.34M
EVAX annual revenue is $3.34 million

Revenue Analysts estimate

$3.66M
EVAX annual revenue is currently -8.70% lower than the consensus analysts' forecast

Revenue 1-year change

+4480.82%
EVAX annual revenue is up +4480.82% year-on-year

Revenue Sector rank

19.22%
EVAX annual revenue is higher than 19.22% of companies in Healthcare sector

EPS

EPS

-$10.00
EVAX annual earnings per share is -$10.00

EPS Analysts estimate

-$1.79
EVAX annual earnings per share is currently +459.69% higher than the consensus analysts' forecast

EPS 1-year change

+75.31%
EVAX annual earnings per share is up +75.31% year-on-year

EPS Sector rank

12.34%
EVAX annual earnings per share is higher than 12.34% of companies in Healthcare sector

Profit

Gross profit

-
EVAX annual gross profit value is unknown

Gross margin

-
EVAX annual gross profit margin value is unknown

Operating profit

-$14.73M
EVAX annual operating income is -$14.73 million

Operating margin

-440.55%
EVAX annual operating profit margin is -440.55%

Net income

-$10.57M
EVAX annual net profit is -$10.57 million

Net margin

-316.00%
EVAX annual net profit margin is -316.00%

Expenses

Total expenses

$18.08M
EVAX annual total expenses is $18.08 million

Operating expenses

$18.08M
EVAX annual total operating expenses is $18.08 million

Cost of goods sold

-
EVAX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$7.32M
EVAX annual SGA is $7.32 million

Depreciation and amortization

$607.00K
EVAX annual depreciation & amortization is $607.00 thousand

Interest expense

$962.00K
EVAX annual interest expense is $962.00 thousand

Income tax

-$788.00K
EVAX annual income tax is -$788.00 thousand

EBIT & EBITDA

EBIT

-$10.39M
EVAX annual earnings before interest & taxes is -$10.39 million

EBITDA

-$9.79M
EVAX annual EBITDA is -$9.79 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$12.48M
EVAX annual total assets is $12.48 million

Non current assets

$3.72M
EVAX annual long term assets is $3.72 million

Current assets

$8.77M
EVAX annual total current assets is $8.77 million

Cash and cash equivalents

$5.05M
EVAX annual cash & cash equivalents is $5.05 million

Accounts receivable

-
EVAX annual accounts receivable value is unknown

Inventory

-
EVAX annual inventory value is unknown

Liabilities

Total liabilities

$14.14M
EVAX annual total liabilities is $14.14 million

Long term liabilities

$9.77M
EVAX annual total long term liabilities is $9.77 million

Current liabilities

$4.37M
EVAX annual total current liabilities is $4.37 million

Accounts payable

$2.97M
EVAX annual accounts payable is $2.97 million

Debt

Total debt

$10.10M
EVAX annual total debt is $10.10 million

Total debt 1-year change

-7.07%
EVAX annual total debt is down -7.07% year-on-year

Long term debt

$9.63M
EVAX annual long term debt is $9.63 million

Short term debt

$473.00K
EVAX annual short term debt is $473.00 thousand

Equity & Capital

Shareholders equity

-$1.65M
EVAX annual stockholders equity is -$1.65 million

Book value

-$1.65M
EVAX annual book value is -$1.65 million

Retained earnings

-$118.54M
EVAX annual retained earnings is -$118.54 million

Working capital

$4.40M
EVAX annual working capital is $4.40 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.94M
EVAX annual cash flow from operations is -$12.94 million

Cash from operations 1-year change

+26.86%
EVAX annual cash flow from operations is up +26.86% year-on-year

Cash from investing

-$3000.00
EVAX annual cash flow from investing activities is -$3000.00

Cash from investing 1-year change

+96.77%
EVAX annual cash flow from investing activities is up +96.77% year-on-year

Cash from financing

$13.13M
EVAX annual cash flow from financing activities is $13.13 million

Cash from financing 1-year change

+22.8%
EVAX annual cash flow from financing activities is up +22.8% year-on-year

CAPEX

CAPEX

-
EVAX annual capital expenditures value is unknown

CAPEX 1-year change

-
EVAX annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$12.94M
EVAX annual free cash flow is -$12.94 million

Free cash flow 1-year change

+27.21%
EVAX annual free cash flow is up +27.21% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
EVAX annual gross profit margin value is unknown

Operating margin

-440.55%
EVAX annual operating profit margin is -440.55%

Net margin

-316.00%
EVAX annual net profit margin is -316.00%

ROA & ROE

ROA

-83.29%
EVAX annual return on assets is -83.29%

ROE

639.65%
EVAX annual return on equity is 639.65%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
EVAX price to earnings ratio value is unknown

PE ratio Sector rank

-
EVAX price to earnings ratio is unknown

PB Ratio

PB ratio

-5.01
EVAX price to book ratio is -5.01

PB ratio Sector rank

3.7%
EVAX price to book ratio is higher than 3.7% of companies in Healthcare sector

PS Ratio

PS ratio

2.47
EVAX price to sales ratio is 2.47

PS ratio Sector rank

47.31%
EVAX price to sales ratio is higher than 47.31% of companies in Healthcare sector

Enterprise value

Enterprise value

$13.32M
EVAX enterprise value is $13.32 million

Enterprise value Sector rank

27.87%
EVAX enterprise value is higher than 27.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-1.09
EVAX EV/EBITDA is -1.09

EV/EBITDA Sector rank

40.99%
EVAX EV/EBITDA is higher than 40.99% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.01
EVAX annual current ratio is 2.01

Quick ratio

-
EVAX annual quick ratio value is unknown

Leverage

Debt to equity

-4.94
EVAX annual debt to equity ratio is -4.94

Interest coverage ratio

-10.80
EVAX annual interest coverage ratio is -10.80

Risk & Stability

Piotroski F-Score

-
EVAX piotroski f-score value is unknown

Altman Z-Score

-15.00
EVAX altman z-score is -15.00

Analyst ratings

Recent major analysts updates

Apr 2, 25 HC Wainwright & Co.
Buy
Feb 20, 25 HC Wainwright & Co.
Buy
Feb 4, 25 Lake Street
Buy
Feb 3, 25 HC Wainwright & Co.
Buy
Nov 1, 24 HC Wainwright & Co.
Buy
Sep 26, 24 HC Wainwright & Co.
Buy
Sep 20, 24 HC Wainwright & Co.
Buy
Aug 16, 24 HC Wainwright & Co.
Buy
Aug 1, 24 HC Wainwright & Co.
Buy
Jun 4, 24 HC Wainwright & Co.
Buy

Institutional Ownership

Similar stocks

KPRX logo
Kiora Pharmaceuticals (KPRX)
Gelteq Limited (GELS)
DHAI logo
DIH Holdings US Class A (DHAI)
AIMD logo
Ainos (AIMD)
APRE logo
Aprea Therapeutics (APRE)
OSA logo
ProSomnus (OSA)
PRPO logo
Precipio (PRPO)
CARM logo
Carisma Therapeutics (CARM)
Scienture Holdings (SCNX)
  • What is the ticker symbol for Evaxion Biotech A/S?
  • Does Evaxion Biotech A/S pay dividends?
  • What sector is Evaxion Biotech A/S in?
  • What industry is Evaxion Biotech A/S in?
  • What country is Evaxion Biotech A/S based in?
  • When did Evaxion Biotech A/S go public?
  • Is Evaxion Biotech A/S in the S&P 500?
  • Is Evaxion Biotech A/S in the NASDAQ 100?
  • Is Evaxion Biotech A/S in the Dow Jones?
  • When was Evaxion Biotech A/S's last earnings report?
  • When does Evaxion Biotech A/S report earnings?
  • Should I buy Evaxion Biotech A/S stock now?

What is the ticker symbol for Evaxion Biotech A/S?

The ticker symbol for Evaxion Biotech A/S is NASDAQ:EVAX

Does Evaxion Biotech A/S pay dividends?

No, Evaxion Biotech A/S does not pay dividends

What sector is Evaxion Biotech A/S in?

Evaxion Biotech A/S is in the Healthcare sector

What industry is Evaxion Biotech A/S in?

Evaxion Biotech A/S is in the Biotechnology industry

What country is Evaxion Biotech A/S based in?

Evaxion Biotech A/S is headquartered in Denmark

When did Evaxion Biotech A/S go public?

Evaxion Biotech A/S's initial public offering (IPO) was on February 5, 2021

Is Evaxion Biotech A/S in the S&P 500?

No, Evaxion Biotech A/S is not included in the S&P 500 index

Is Evaxion Biotech A/S in the NASDAQ 100?

No, Evaxion Biotech A/S is not included in the NASDAQ 100 index

Is Evaxion Biotech A/S in the Dow Jones?

No, Evaxion Biotech A/S is not included in the Dow Jones index

When was Evaxion Biotech A/S's last earnings report?

Evaxion Biotech A/S's most recent earnings report was on Apr 1, 2025

When does Evaxion Biotech A/S report earnings?

The next expected earnings date for Evaxion Biotech A/S is May 28, 2025

Should I buy Evaxion Biotech A/S stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page